At early stages, tumor lesions represent a higher expression of immune stimulatory genes (MHC-II, etc.)s resembling a proinflammatory M1-like phenotype; when progressing to advanced invasive cancer, the expression of immunosuppressive gene (CD206, etc.)is significantly upregulated, becoming the M2-like phenotype [46]. The gene discussed is MRC1; the disease is neoplasm.